化合物GLPG2938 T9199
品牌 | 厂商性质 | 产地 | 货期 |
---|---|---|---|
TargetMol | 生产商 | 美国 | 现货 |
性能特点
生化试剂,可用于动物细胞实验
规格 | CAS号 | 价格 | 操作 |
---|---|---|---|
50 mg | 2130996-00-6 | ¥6,780.00 | 询底价 |
5 mg | 2130996-00-6 | ¥1,620.00 | 询底价 |
100 mg | 2130996-00-6 | ¥9,190.00 | 询底价 |
1 mL | 2130996-00-6 | ¥1,790.00 | 询底价 |
25 mg | 2130996-00-6 | ¥4,750.00 | 询底价 |
10 mg | 2130996-00-6 | ¥2,860.00 | 询底价 |
1 mg | 2130996-00-6 | ¥598.00 | 询底价 |
Product Introduction
Bioactivity
英文名: GLPG2938
描述: GLPG2938 (1-(2-Ethoxy-6-(trifluoromethyl)pyridin-4-yl)-3-((5-methyl-6-(1-methyl-3-(trifluoromethyl)-1H-pyrazol-4-yl)pyridazin-3-yl)methyl)urea) 是一种选择性 S1P2拮抗剂,可用于特发性肺纤维化的研究。
体外活性: GLPG2938在所有测试浓度下显著阻止了S1P介导的收缩[1]。
体内活性: In all species ,GLPG2938 shows good pharmacokinetics, with long half-life,low clearance,and good bioavailability.
存储条件: Powder: -20°C for 3 years | In solvent: -80°C for 1 year
溶解度: DMSO : 60 mg/ml (119.19 mM)
关键字: Lysophospholipid Receptor | GLPG 2938 | fibrosis | inhibit | GLPG2938 | LPL Receptor | GLPG-2938 | selective | pulmonary | Inhibitor | potent | idiopathic
相关产品: Phorbol 12-myristate 13-acetate | Opaganib | K6PC-5 | PF-543 hydrochloride | Fingolimod | Fingolimod hydrochloride | ASP-4058 | GSK2018682 | SLP9101555 | TY-52156
相关库: Membrane Protein-targeted Compound Library | Bioactive Compounds Library Max | GPCR Compound Library | Inhibitor Library | NO PAINS Compound Library | Bioactive Compound Library
化合物GLPG2938 T9199信息由TargetMol中国为您提供,如您想了解更多关于化合物GLPG2938 T9199报价、型号、参数等信息,欢迎来电或留言咨询。
注:该产品未在中华人民共和国食品药品监督管理部门申请医疗器械注册和备案,不可用于临床诊断或治疗等相关用途